A role for epigenetics in hearing: Establishment and maintenance of auditory specific gene expression patterns

Hearing Research

Volumn 233, Issue 1-2, 2007, Pages 1-13

  Provenzano, Matthew J ^a   Domann, Frederick E ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Deafness; DNA methylation; Hair cells; Histone modifications; Organ of Corti; Presbycusis

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; CASPASE 8; CISPLATIN; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3B; DNA METHYLTRANSFERASE INHIBITOR; HISTONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; POTASSIUM CHANNEL KCNQ1; PROTEIN; PROTEIN CHD7; PROTEIN COL11A1; PROTEIN COL2A1; PROTEIN D4Z4; PROTEIN KCNQ1OT1; PROTEIN MCCP2; PROTEIN NF2; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; REACTIVE OXYGEN METABOLITE; RETINOBLASTOMA PROTEIN; TRICHOSTATIN A; UNCLASSIFIED DRUG; VALPROIC ACID; VITAMIN; ZEBULARINE;

ACETYLATION; ANGIOGENESIS; BECKWITH WIEDEMANN SYNDROME; BIOLOGICAL ACTIVITY; CANCER; CANCER CHEMOTHERAPY; CANCER GENETICS; CELL DIFFERENTIATION; COCHLEAR NERVE; DNA METHYLATION; DNA MODIFICATION; DRUG POTENTIATION; EPIGENETICS; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE EXPRESSION; HEARING; HEARING IMPAIRMENT; HEARING LOSS; HUMAN; HUMAN DEVELOPMENT; IMMUNODEFICIENCY CENTROMERIC INSTABILITY FACIAL ANOMALIES SYNDROME; MEDICAL RESEARCH; METHYLATION; MOLECULAR INTERACTION; NERVE CELL; NERVE GROWTH; NEURILEMOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; OCULOOTORADIAL SYNDROME; PRIORITY JOURNAL; RETINOBLASTOMA; RETT SYNDROME; REVIEW; SOUND; SYNDROME; SYNDROME CHARGE; TARGET CELL; VESTIBULAR DISORDER;

ACETYLATION; ANIMALS; DNA METHYLATION; EMBRYONIC DEVELOPMENT; EPIGENESIS, GENETIC; GENE EXPRESSION; HEARING; HEARING LOSS; HISTONES; HUMANS; METHYLATION; NEOPLASMS;

EID: 34848915499     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.heares.2007.07.002     Document Type: Review

References (126)

1. Annunen S., Korkko J., Czarny M., Warman M.L., Brunner H.G., Kaariainen H., Mulliken J.B., Tranebjaerg L., Brooks D.G., Cox G.F., Cruysberg J.R., Curtis M.A., Davenport S.L., Friedrich C.A., Kaitila I., Krawczynski M.R., Latos-Bielenska A., Mukai S., Olsen B.R., Shinno N., Somer M., Vikkula M., Zlotogora J., Prockop D.J., and Ala-Kokko L. Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am. J. Hum. Genet. 65 (1999) 974-983
2. Avila A.M., Burnett B.G., Taye A.A., Gabanella F., Knight M.A., Hartenstein P., Cizman Z., Di Prospero N.A., Pellizzoni L., Fischbeck K.H., and Sumner C.J. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J. Clin. Invest. 117 (2007) 659-671
3. Bacolla A., Pradhan S., Roberts R.J., and Wells R.D. Recombinant human DNA (cytosine-5) methyltransferase. II. Steady-state kinetics reveal allosteric activation by methylated dna. J. Biol. Chem. 274 (1999) 33011-33019
4. Bacolla A., Pradhan S., Larson J.E., Roberts R.J., and Wells R.D. Recombinant human DNA (cytosine-5) methyltransferase. III. Allosteric control, reaction order, and influence of plasmid topology and triplet repeat length on methylation of the fragile X CGG.CCG sequence. J. Biol. Chem. 276 (2001) 18605-18613
5. Balasubramaniyan V., Boddeke E., Bakels R., Kust B., Kooistra S., Veneman A., and Copray S. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells. Neuroscience 143 (2006) 939-951
6. Bannister A.J., Schneider R., and Kouzarides T. Histone methylation: dynamic or static?. Cell 109 (2002) 801-806
7. Bao N., Lye K.W., and Barton M.K. MicroRNA binding sites in Arabidopsis class III HD-ZIP mRNAs are required for methylation of the template chromosome. Dev. Cell 7 (2004) 653-662
8. Baylin S.B., Belinsky S.A., and Herman J.G. Aberrant methylation of gene promoters in cancer---concepts, misconcepts, and promise. J. Natl. Cancer Inst. 92 (2000) 1460-1461
9. Beisel K.W., Rocha-Sanchez S.M., Morris K.A., Nie L., Feng F., Kachar B., Yamoah E.N., and Fritzsch B. Differential expression of KCNQ4 in inner hair cells and sensory neurons is the basis of progressive high-frequency hearing loss. J. Neurosci. 25 (2005) 9285-9293
10. Best L.G. Familial posterior helical ear pits and Wiedemann-Beckwith syndrome. Am. J. Med. Genet. 40 (1991) 188-195
11. Bhattacharya S.K., Ramchandani S., Cervoni N., and Szyf M. A mammalian protein with specific demethylase activity for mCpG DNA. Nature 397 (1999) 579-583
12. Bienz M., and Clevers H. Armadillo/beta-catenin signals in the nucleus--proof beyond a reasonable doubt?. Nat. Cell Biol. 5 (2003) 179-182
13. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 16 (2002) 6-21
14. Boeke J., Ammerpohl O., Kegel S., Moehren U., and Renkawitz R. The minimal repression domain of MBD2b overlaps with the methyl-CpG-binding domain and binds directly to Sin3A. J. Biol. Chem. 275 (2000) 34963-34967
15. Braegger C., Bottani A., Halle F., Giedion A., Leumann E., Seger R., Willi U., and Schinzel A. Unknown syndrome: ischiadic hypoplasia, renal dysfunction, immunodeficiency, and a pattern of minor congenital anomalies. J. Med. Genet. 28 (1991) 56-59
16. Brouwer O.F., Padberg G.W., Ruys C.J., Brand R., de Laat J.A., and Grote J.J. Hearing loss in facioscapulohumeral muscular dystrophy. Neurology 41 (1991) 1878-1881
17. Buschdorf J.P., and Stratling W.H. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome. J. Mol. Med. 82 (2004) 135-143
18. Cameron E.E., Bachman K.E., Myohanen S., Herman J.G., and Baylin S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 21 (1999) 103-107
19. Chen R.Z., Akbarian S., Tudor M., and Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 27 (2001) 327-331
20. Chen T., Ueda Y., Xie S., and Li E. A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation. J. Biol. Chem. 277 (2002) 38746-38754
21. Chow J.C., Yen Z., Ziesche S.M., and Brown C.J. Silencing of the mammalian X chromosome. Annu. Rev. Genomics Hum. Genet. 6 (2005) 69-92
22. Cross S.H., Meehan R.R., Nan X., and Bird A. A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins. Nat. Genet. 16 (1997) 256-259
23. Cuthbert G.L., Daujat S., Snowden A.W., Erdjument-Bromage H., Hagiwara T., Yamada M., Schneider R., Gregory P.D., Tempst P., Bannister A.J., and Kouzarides T. Histone deimination antagonizes arginine methylation. Cell 118 (2004) 545-553
24. Daugbjerg P., and Everberg G. A case of Beckwith-Wiedemann syndrome with conductive hearing loss. Acta Paediatr. Scand. 73 (1984) 408-410
25. Dean W., Lucifero D., and Santos F. DNA methylation in mammalian development and disease. Birth Defects Res. C Embryo Today 75 (2005) 98-111
26. Dion M.F., Altschuler S.J., Wu L.F., and Rando O.J. Genomic characterization reveals a simple histone H4 acetylation code. Proc. Natl. Acad. Sci .USA 102 (2005) 5501-5506
27. Dong E., Guidotti A., Grayson D.R., and Costa E. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc. Natl. Acad. Sci. USA 104 (2007) 4676-4681
28. Elcioglu N., and Berry A.C. Monozygotic twins discordant for the oculo-oto-radial syndrome (IVIC syndrome). Genet. Couns. 8 (1997) 201-206
29. Fischer A., Sananbenesi F., Wang X., Dobbin M., and Tsai L.H. Recovery of learning and memory is associated with chromatin remodelling. Nature (2007)
30. Furuya F., Shimura H., Suzuki H., Taki K., Ohta K., Haraguchi K., Onaya T., Endo T., and Kobayashi T. Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium/iodide symporter thyroperoxidase and thyroglobulin. Endocrinology 145 (2004) 2865-2875
31. Ghoshal K., Datta J., Majumder S., Bai S., Dong X., Parthun M., and Jacob S.T. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Mol. Cell. Biol. 22 (2002) 8302-8319
32. Gilbert J., Gore S.D., Herman J.G., and Carducci M.A. The clinical application of targeting cancer through histone acetylation and hypomethylation. Clin. Cancer Res. 10 (2004) 4589-4596
33. Goll M.G., Kirpekar F., Maggert K.A., Yoder J.A., Hsieh C.L., Zhang X., Golic K.G., Jacobsen S.E., and Bestor T.H. Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science 311 (2006) 395-398
34. Gonzalez-Gomez P., Bello M.J., Alonso M.E., Lomas J., Arjona D., Campos J.M., Vaquero J., Isla A., Lassaletta L., Gutierrez M., Sarasa J.L., and Rey J.A. CpG island methylation in sporadic and neurofibromatis type 2-associated schwannomas. Clin. Cancer Res. 9 (2003) 5601-5606
35. Groth A., Rocha W., Verreault A., and Almouzni G. Chromatin challenges during DNA replication and repair. Cell 128 (2007) 721-733
36. Hajkova P., Erhardt S., Lane N., Haaf T., El-Maarri O., Reik W., Walter J., and Surani M.A. Epigenetic reprogramming in mouse primordial germ cells. Mech. Dev. 117 (2002) 15-23
37. Hata K., Okano M., Lei H., and Li E. Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development 129 (2002) 1983-1993
38. Hellebrekers D.M., Griffioen A.W., and van Engeland M. Dual targeting of epigenetic therapy in cancer. Biochim. Biophys. Acta. 1775 (2007) 76-91
39. Hellebrekers D.M., Jair K.W., Vire E., Eguchi S., Hoebers N.T., Fraga M.F., Esteller M., Fuks F., Baylin S.B., van Engeland M., and Griffioen A.W. Angiostatic activity of DNA methyltransferase inhibitors. Mol. Cancer Ther. 5 (2006) 467-475
40. Hermann A., Gowher H., and Jeltsch A. Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol. Life Sci. 61 (2004) 2571-2587
41. Hibino H., Pironkova R., Onwumere O., Rousset M., Charnet P., Hudspeth A.J., and Lesage F. Direct interaction with a nuclear protein and regulation of gene silencing by a variant of the Ca2+ channel beta 4 subunit. Proc. Natl. Acad. Sci. USA 100 (2003) 307-312
42. Hirokawa Y., Nakajima H., Hanemann C.O., Kurtz A., Frahm S., Mautner V., and Maruta H. Signal therapy of NF1-deficient tumor xenograft in mice by the anti-PAK1 drug FK228. Cancer Biol. Ther. 4 (2005) 379-381
43. Hitchler, M.J., Domann, F.E., 2007. An epigenetic perspective on the free radical theory of development. Free Radic. Biol. Med., in press, doi:10.1016/j.freeradbiomed.2007.06.027.
44. Hitchler M.J., Wikainapakul K., Yu L., Powers K., Attatippaholkun W., and Domann F.E. Epigenetic regulation of manganese superoxide dismutase expression in human breast cancer cells. Epigenetics 1 (2006) 163-171
45. Issa J.P., Ahuja N., Toyota M., Bronner M.P., and Brentnall T.A. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 61 (2001) 3573-3577
46. Issa J.P., Gharibyan V., Cortes J., Jelinek J., Morris G., Verstovsek S., Talpaz M., Garcia-Manero G., and Kantarjian H.M. Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate. J. Clin. Oncol. 23 (2005) 3948-3956
47. Januchowski R., Prokop J., and Jagodzinski P.P. Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. J. Appl. Genet. 45 (2004) 237-248
48. Jeanpierre M., Turleau C., Aurias A., Prieur M., Ledeist F., Fischer A., and Viegas-Pequignot E. An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. Hum. Mol. Genet. 2 (1993) 731-735
49. Jiang H., Sha S.H., and Schacht J. Kanamycin alters cytoplasmic and nuclear phosphoinositide signaling in the organ of Corti in vivo. J. Neurochem. 99 (2006) 269-276
50. Jones P.A., and Baylin S.B. The epigenomics of cancer. Cell 128 (2007) 683-692
51. Kiernan A.E., Pelling A.L., Leung K.K., Tang A.S., Bell D.M., Tease C., Lovell-Badge R., Steel K.P., and Cheah K.S. Sox2 is required for sensory organ development in the mammalian inner ear. Nature 434 (2005) 1031-1035
52. Kim T.H., Barrera L.O., Zheng M., Qu C., Singer M.A., Richmond T.A., Wu Y., Green R.D., and Ren B. A high-resolution map of active promoters in the human genome. Nature 436 (2005) 876-880
53. Kim T.S., Nakagawa T., Endo T., Iguchi F., Murai N., Naito Y., and Ito J. Alteration of E-cadherin and beta-catenin in mouse vestibular epithelia during induction of apoptosis. Neurosci. Lett. 329 (2002) 173-176
54. Kino T., Takeshima H., Nakao M., Nishi T., Yamamoto K., Kimura T., Saito Y., Kochi M., Kuratsu J., Saya H., and Ushio Y. Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma. Genes Cells 6 (2001) 441-454
55. Kohlmaier A., Savarese F., Lachner M., Martens J., Jenuwein T., and Wutz A. A chromosomal memory triggered by Xist regulates histone methylation in X inactivation. PLoS Biol. 2 (2004) E171
56. Kouzarides T. Chromatin modifications and their function. Cell 128 (2007) 693-705
57. Kurdistani S.K., Tavazoie S., and Grunstein M. Mapping global histone acetylation patterns to gene expression. Cell 117 (2004) 721-733
58. Lachner M., and Jenuwein T. The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14 (2002) 286-298
59. Lalani S.R., Safiullah A.M., Fernbach S.D., Harutyunyan K.G., Thaller C., Peterson L.E., McPherson J.D., Gibbs R.A., White L.D., Hefner M., Davenport S.L., Graham J.M., Bacino C.A., Glass N.L., Towbin J.A., Craigen W.J., Neish S.R., Lin A.E., and Belmont J.W. Spectrum of CHD7 Mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am. J. Hum. Genet. 78 (2006) 303-314
60. Lassaletta L., Bello M.J., Del Rio L., Alfonso C., Roda J.M., Rey J.A., and Gavilan J. DNA methylation of multiple genes in vestibular schwannoma: relationship with clinical and radiological findings. Otol. Neurotol. 27 (2006) 1180-1185
61. Li B., Carey M., and Workman J.L. The role of chromatin during transcription. Cell 128 (2007) 707-719
62. Li E., Bestor T.H., and Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69 (1992) 915-926
63. Lohmann D.R., Gerick M., Brandt B., Oelschlager U., Lorenz B., Passarge E., and Horsthemke B. Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma. Am. J. Hum. Genet. 61 (1997) 282-294
64. Lucifero D., Mann M.R., Bartolomei M.S., and Trasler J.M. Gene-specific timing and epigenetic memory in oocyte imprinting. Hum. Mol. Genet. 13 (2004) 839-849
65. Marushige Y., and Marushige K. Disappearance of ubiquitinated histone H2A during chromatin condensation in TGF beta 1-induced apoptosis. Anticancer Res. 15 (1995) 267-272
66. Matsuda M., and Keino H. Roles of beta-catenin in inner ear development in rat embryos. Anat. Embryol. (Berl) 202 (2000) 39-48
67. Meehan R.R., Dunican D.S., Ruzov A., and Pennings S. Epigenetic silencing in embryogenesis. Exp. Cell Res. 309 (2005) 241-249
68. Meyerson M.D., Lewis E., and Ill K. Facioscapulohumeral muscular dystrophy and accompanying hearing loss. Arch. Otolaryngol. 110 (1984) 261-266
69. Monier K., Mouradian S., and Sullivan K.F. DNA methylation promotes Aurora-B-driven phosphorylation of histone H3 in chromosomal subdomains. J. Cell. Sci. 120 (2007) 101-114
70. Morel J.B., Mourrain P., Beclin C., and Vaucheret H. DNA methylation and chromatin structure affect transcriptional and post-transcriptional transgene silencing in Arabidopsis. Curr. Biol. 10 (2000) 1591-1594
71. Murrell A., Heeson S., Cooper W.N., Douglas E., Apostolidou S., Moore G.E., Maher E.R., and Reik W. An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype. Hum. Mol. Genet. 13 (2004) 247-255
72. Mutskov V., and Felsenfeld G. Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. Embo. J. 23 (2004) 138-149
73. Naim R., Chang R.C., Anders C., Sadick H., Riedel F., Bayerl C., Bran G., and Hormann K. Up-regulation of beta-catenin in external auditory canal cholesteatoma. Int. J. Mol. Med. 15 (2005) 801-804
74. Nicolas E., Yamada T., Cam H.P., Fitzgerald P.C., Kobayashi R., and Grewal S.I. Distinct roles of HDAC complexes in promoter silencing, antisense suppression and DNA damage protection. Nat. Struct. Mol. Biol. 14 (2007) 372-380
75. Ohyama T., Mohamed O.A., Taketo M.M., Dufort D., and Groves A.K. Wnt signals mediate a fate decision between otic placode and epidermis. Development 133 (2006) 865-875
76. Okano M., Xie S., and Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19 (1998) 219-220
77. Okano M., Bell D.W., Haber D.A., and Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99 (1999) 247-257
78. Oki M., Aihara H., and Ito T. Role of histone phosphorylation in chromatin dynamics and its implications in diseases. Subcell Biochem. 41 (2007) 319-336
79. Oshiro M.M., Watts G.S., Wozniak R.J., Junk D.J., Munoz-Rodriguez J.L., Domann F.E., and Futscher B.W. Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene 22 (2003) 3624-3634
80. Papaggeli P.C., Kortsaris A.C., and Matsouka P.T. Aberrant methylation of c-myc and c-fos protooncogenes and p53 tumor suppressor gene in myelodysplastic syndromes and acute non-lymphocytic leukemia. J. Buon. 8 (2003) 341-350
81. Penterman J., Zilberman D., Huh J.H., Ballinger T., Henikoff S., and Fischer R.L. DNA demethylation in the Arabidopsis genome. Proc. Natl. Acad. Sci. USA 104 (2007) 6752-6757
82. Pradhan S., Bacolla A., Wells R.D., and Roberts R.J. Recombinant human DNA (cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and maintenance methylation. J. Biol. Chem. 274 (1999) 33002-33010
83. Qu G., Dubeau L., Narayan A., Yu M.C., and Ehrlich M. Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. Mutat. Res. 423 (1999) 91-101
84. Riccomagno M.M., Takada S., and Epstein D.J. Wnt-dependent regulation of inner ear morphogenesis is balanced by the opposing and supporting roles of Shh. Genes. Dev. 19 (2005) 1612-1623
85. Richards E.J., and Elgin S.C. Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell 108 (2002) 489-500
86. Rivas A., and Francis H.W. Inner ear abnormalities in a Kcnq1 (Kvlqt1) knockout mouse: a model of Jervell and Lange-Nielsen syndrome. Otol Neurotol. 26 (2005) 415-424
87. Robertson K.D. DNA methylation and human disease. Nat. Rev. Genet. 6 (2005) 597-610
88. Roman-Gomez J., Jimenez-Velasco A., Agirre X., Castillejo J.A., Navarro G., Jose-Eneriz E.S., Garate L., Cordeu L., Cervantes F., Prosper F., Heiniger A., and Torres A. Epigenetic regulation of PRAME gene in chronic myeloid leukemia. Leuk. Res. (2007)
89. Ronemus M., and Martienssen R. RNA interference: methylation mystery. Nature 433 (2005) 472-473
90. Sage C., Huang M., Vollrath M.A., Brown M.C., Hinds P.W., Corey D.P., Vetter D.E., and Chen Z.Y. Essential role of retinoblastoma protein in mammalian hair cell development and hearing. Proc. Natl. Acad. Sci. USA 103 (2006) 7345-7350
91. Saito Y., and Jones P.A. Epigenetic activation of tumor suppressor microRNAs in human cancer cells. Cell Cycle 5 (2006) 2220-2222
92. Sakai T., Ohtani N., McGee T.L., Robbins P.D., and Dryja T.P. Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature 353 (1991) 83-86
93. Santos-Rosa H., Schneider R., Bannister A.J., Sherriff J., Bernstein B.E., Emre N.C., Schreiber S.L., Mellor J., and Kouzarides T. Active genes are tri-methylated at K4 of histone H3. Nature 419 (2002) 407-411
94. Schocket L.S., Beaverson K.L., Rollins I.S., and Abramson D.H. Bilateral retinoblastoma, microphthalmia, and colobomas in the 13q deletion syndrome. Arch. Ophthalmol. 121 (2003) 916-917
95. Schuettengruber B., Chourrout D., Vervoort M., Leblanc B., and Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell 128 (2007) 735-745
96. Shames D.S., Minna J.D., and Gazdar A.F. DNA methylation in health, disease, and cancer. Curr. Mol. Med. 7 (2007) 85-102
97. Shi Y., Lan F., Matson C., Mulligan P., Whetstine J.R., Cole P.A., Casero R.A., and Shi Y. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119 (2004) 941-953
98. Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu. Rev. Biochem. 75 (2006) 243-269
99. Siebzehnrubl F.A., Buslei R., Eyupoglu I.Y., Seufert S., Hahnen E., and Blumcke I. Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cells. Exp. Brain Res. 176 (2007) 672-678
100. Stacey M., Bennett M.S., and Hulten M. FISH analysis on spontaneously arising micronuclei in the ICF syndrome. J. Med. Genet. 32 (1995) 502-508
101. Stevens C.B., Davies A.L., Battista S., Lewis J.H., and Fekete D.M. Forced activation of Wnt signaling alters morphogenesis and sensory organ identity in the chicken inner ear. Dev. Biol. 261 (2003) 149-164
102. Stickler G.B., Hughes W., and Houchin P. Clinical features of hereditary progressive arthro-ophthalmopathy (Stickler syndrome): a survey. Genet. Med. 3 (2001) 192-196
103. Takebayashi S., Nakagawa T., Kojima K., Kim T.S., Endo T., Iguchi F., Kita T., Yamamoto N., and Ito J. Nuclear translocation of beta-catenin in developing auditory epithelia of mice. Neuroreport 16 (2005) 431-434
104. Tate P.H., and Bird A.P. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr. Opin. Genet. Dev. 3 (1993) 226-231
105. Tong J.K., Hassig C.A., Schnitzler G.R., Kingston R.E., and Schreiber S.L. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 395 (1998) 917-921
106. Tsuji-Takayama K., Inoue T., Ijiri Y., Otani T., Motoda R., Nakamura S., and Orita K. Demethylating agent, 5-azacytidine, reverses differentiation of embryonic stem cells. Biochem. Biophys. Res. Commun. 323 (2004) 86-90
107. Uchida D., Begum N.M., Almofti A., Kawamata H., Yoshida H., and Sato M. Frequent downregulation of 14-3-3 sigma protein and hypermethylation of 14-3-3 sigma gene in salivary gland adenoid cystic carcinoma. Br. J. Cancer 91 (2004) 1131-1138
108. Vairapandi M. Characterization of DNA demethylation in normal and cancerous cell lines and the regulatory role of cell cycle proteins in human DNA demethylase activity. J. Cell Biochem. 91 (2004) 572-583
109. van Geel M., Dickson M.C., Beck A.F., Bolland D.J., Frants R.R., van der Maarel S.M., de Jong P.J., and Hewitt J.E. Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin. Genomics 79 (2002) 210-217
110. van Overveld P.G., Lemmers R.J., Sandkuijl L.A., Enthoven L., Winokur S.T., Bakels F., Padberg G.W., van Ommen G.J., Frants R.R., and van der Maarel S.M. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat. Genet. 35 (2003) 315-317
111. Vaucheret H., and Fagard M. Transcriptional gene silencing in plants: targets, inducers and regulators. Trends Genet. 17 (2001) 29-35
112. Vilain A., Bernardino J., Gerbault-Seureau M., Vogt N., Niveleau A., Lefrancois D., Malfoy B., and Dutrillaux B. DNA methylation and chromosome instability in lymphoblastoid cell lines. Cytogenet. Cell Genet. 90 (2000) 93-101
113. Volpe T.A., Kidner C., Hall I.M., Teng G., Grewal S.I., and Martienssen R.A. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 297 (2002) 1833-1837
114. Wade P.A., Gegonne A., Jones P.L., Ballestar E., Aubry F., and Wolffe A.P. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat. Genet. 23 (1999) 62-66
115. Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P., Jones R.S., and Zhang Y. Role of histone H2A ubiquitination in Polycomb silencing. Nature 431 (2004) 873-878
116. Wassenegger M., Heimes S., Riedel L., and Sanger H.L. RNA-directed de novo methylation of genomic sequences in plants. Cell 76 (1994) 567-576
117. Weksberg R., Shuman C., Caluseriu O., Smith A.C., Fei Y.L., Nishikawa J., Stockley T.L., Best L., Chitayat D., Olney A., Ives E., Schneider A., Bestor T.H., Li M., Sadowski P., and Squire J. Discordant KCNQ1OT1 imprinting in sets of monozygotic twins discordant for Beckwith-Wiedemann syndrome. Hum. Mol. Genet. 11 (2002) 1317-1325
118. Wilkin D.J., Liberfarb R., Davis J., Levy H.P., Cole W.G., Francomano C.A., and Cohn D.H. Rapid determination of COL2A1 mutations in individuals with Stickler syndrome: analysis of potential premature termination codons. Am. J. Med. Genet. 94 (2000) 141-148
119. Willert K., and Jones K.A. Wnt signaling: is the party in the nucleus?. Genes. Dev. 20 (2006) 1394-1404
120. Wilson A.S., Power B.E., and Molloy P.L. DNA hypomethylation and human diseases. Biochim. Biophys. Acta. 1775 (2007) 138-162
121. Wood A., Krogan N.J., Dover J., Schneider J., Heidt J., Boateng M.A., Dean K., Golshani A., Zhang Y., Greenblatt J.F., Johnston M., and Shilatifard A. Bre1, an E3 ubiquitin ligase required for recruitment and substrate selection of Rad6 at a promoter. Mol. Cell 11 (2003) 267-274
122. Wutz A., Smrzka O.W., Schweifer N., Schellander K., Wagner E.F., and Barlow D.P. Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature 389 (1997) 745-749
123. Xing M. Gene methylation in thyroid tumorigenesis. Endocrinology 148 (2007) 948-953
124. Yoder J.A., Walsh C.P., and Bestor T.H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13 (1997) 335-340
125. Yoo C.B., Cheng J.C., and Jones P.A. Zebularine: a new drug for epigenetic therapy. Biochem. Soc. Trans. 32 (2004) 910-912
126. Zhang Y., Fatima N., and Dufau M.L. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Mol. Cell. Biol. 25 (2005) 7929-7939